Response to Gammal et al
Genet Med
.
2019 Aug;21(8):1888-1889.
doi: 10.1038/s41436-018-0422-9.
Epub 2019 Jan 12.
Authors
Jason L Vassy
1
2
3
,
Annjanette Stone
4
,
John T Callaghan
5
6
,
Margaret Mendes
7
,
Laurence J Meyer
8
,
Victoria M Pratt
6
,
Ronald M Przygodzki
9
,
Maren T Scheuner
10
11
,
Jessica Wang-Rodriguez
7
12
,
Steven A Schichman
4
;
VHA Clinical Pharmacogenetics Subcommittee
Affiliations
1
Section of General Internal Medicine, VA Boston Healthcare System, Boston, MA, USA.
[email protected]
.
2
Department of Medicine, Harvard Medical School, Boston, MA, USA.
[email protected]
.
3
Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.
[email protected]
.
4
Pharmacogenomics Analysis Laboratory, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA.
5
Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
6
Indiana University School of Medicine, Indianapolis, IN, USA.
7
VA San Diego Healthcare System, San Diego, CA, USA.
8
Office of Specialty Care Services, Veterans Health Administration, Washington, DC, USA.
9
Office of Research & Development, US Department of Veterans Affairs, Washington, DC, USA.
10
Division of Medical Genetics, Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
11
Department of Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA.
12
University of California San Diego, San Diego, CA, USA.
PMID:
30635623
DOI:
10.1038/s41436-018-0422-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Pharmacogenetics
Pharmacogenomic Testing*
United States
United States Department of Veterans Affairs
Veterans Health
Veterans*
Grants and funding
IK2 CX001262/CX/CSRD VA/United States